Taysha Gene Therapies, Inc. - stock earnings
TSHA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 47.7 million USD | 3.6 million USD |
| 2023Q3 | -117.1 million USD | 4.7 million USD |
| 2023Q2 | -24.6 million USD | 2.4 million USD |
| 2023Q1 | -20.1 million USD | 4.7 million USD |
| 2022Q4 | -58.1 million USD | 2.5 million USD |
| 2022Q3 | -27.5 million USD | ? USD |
| 2022Q2 | -34.8 million USD | ? USD |
| 2022Q1 | -51.0 million USD | ? USD |
| 2021Q4 | -50.4 million USD | ? USD |
| 2021Q3 | -51.2 million USD | ? USD |
| 2021Q2 | -40.9 million USD | ? USD |
| 2021Q1 | -32.0 million USD | ? USD |
| 2020Q4 | -18.3 million USD | ? USD |
| 2020Q3 | -15.0 million USD | ? USD |
| 2020Q2 | -21.2 million USD | ? USD |
| 2020Q1 | -5.4 million USD | ? USD |
| 2019Q4 | -1.1 million USD | ? USD |
TSHA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -111.6 million USD | 15.5 million USD |
| 2022 | -169.6 million USD | 2.5 million USD |
| 2021 | -175.5 million USD | ? USD |
| 2020 | -43.0 million USD | ? USD |
| 2019 | -1.1 million USD | ? USD |
TSHA
Price: $2.39
52 week price:
Earnings Per Share: -0.96 USD
P/E Ratio: -0.51
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.1 million
Market Capitalization: 501.2 million